Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Daneshmanesh AH"'
Autor:
Ghaderi A; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden., Daneshmanesh AH; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden., Moshfegh A; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden.; Kancera AB, Karolinska Institute Science Park, 171 48 Solna, Sweden., Kokhaei P; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden.; Department of Immunology, Semnan University of Medical Sciences, Semnan 35147-99442, Iran., Vågberg J; Kancera AB, Karolinska Institute Science Park, 171 48 Solna, Sweden., Schultz J; Kancera AB, Karolinska Institute Science Park, 171 48 Solna, Sweden., Olin T; Kancera AB, Karolinska Institute Science Park, 171 48 Solna, Sweden., Harrysson S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, 171 77 Stockholm, Sweden., Smedby KE; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, 171 77 Stockholm, Sweden., Drakos E; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden.; Department of Pathology, Medical School, University of Crete, 71110 Heraklion Crete, Greece., Rassidakis GZ; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden., Österborg A; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, 171 77 Stockholm, Sweden., Hojjat-Farsangi M; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institutet, 17164 Stockholm, Sweden.
Publikováno v:
Biomedicines [Biomedicines] 2020 Jun 23; Vol. 8 (6). Date of Electronic Publication: 2020 Jun 23.
Autor:
Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Khan AS; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Shetye J; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Mozaffari F; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Kharaziha P; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Rathje LS; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Kancera AB, Solna, Sweden., Kokhaei P; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Cancer Research Center and Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran., Hansson L; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Vågberg J; Kancera AB, Solna, Sweden., Byström S; Kancera AB, Solna, Sweden., Olsson E; Kancera AB, Solna, Sweden., Löfberg C; Kancera AB, Solna, Sweden., Norström C; Kancera AB, Solna, Sweden., Schultz J; Kancera AB, Solna, Sweden., Norin M; Kancera AB, Solna, Sweden., Olin T; Kancera AB, Solna, Sweden., Österborg A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden. hakan.mellstedt@sll.se., Moshfegh A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Kancera AB, Solna, Sweden.
Publikováno v:
Leukemia [Leukemia] 2018 Oct; Vol. 32 (10), pp. 2291-2295. Date of Electronic Publication: 2018 Mar 27.
Autor:
Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden., Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden., Ghaderi A; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden., Moshfegh A; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Schultz J; Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden., Vågberg J; Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden., Byström S; Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden., Olsson E; Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden., Olin T; Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden., Österborg A; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
Publikováno v:
PloS one [PLoS One] 2018 Jun 01; Vol. 13 (6), pp. e0198038. Date of Electronic Publication: 2018 Jun 01 (Print Publication: 2018).
Autor:
Khan AS; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Kokhaei P; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.; Cancer Research Center and Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran., Österborg A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. hakan.mellstedt@karolinska.se.; Cancer Centre Karolinska, Department of Oncology, Karolinska University Hospital Solna, SE-171 76, Stockholm, Sweden. hakan.mellstedt@karolinska.se., Moshfegh A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2016 Sep; Vol. 37 (9), pp. 11947-11957. Date of Electronic Publication: 2016 Apr 16.
Autor:
Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Jeddi-Tehrani M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Mozaffari F; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Moshfegh A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden., Razavi SM; Clinic of Hematology and Oncology, Firozgar Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Sharifian RA; Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Rabbani H; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Österborg A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Publikováno v:
PloS one [PLoS One] 2015 Nov 12; Vol. 10 (11), pp. e0142310. Date of Electronic Publication: 2015 Nov 12 (Print Publication: 2015).
Autor:
Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, CCK, Karolinska Institute and Karolinska University Hospital Solna, Stockholm, Sweden., Hojjat-Farsangi M, Moshfegh A, Khan AS, Mikaelsson E, Österborg A, Mellstedt H
Publikováno v:
British journal of haematology [Br J Haematol] 2015 May; Vol. 169 (3), pp. 455-8. Date of Electronic Publication: 2014 Nov 19.
Autor:
Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Moshfegh A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Khan AS; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Mikaelsson E; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden., Osterborg A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. Electronic address: hakan.mellstedt@karolinska.se.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2014 Dec; Vol. 29, pp. 21-31. Date of Electronic Publication: 2014 Jul 25.
Autor:
Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Khan AS, Daneshmanesh AH, Moshfegh A, Sandin A, Mansouri L, Palma M, Lundin J, Österborg A, Mellstedt H
Publikováno v:
PloS one [PLoS One] 2013 Oct 24; Vol. 8 (10), pp. e78339. Date of Electronic Publication: 2013 Oct 24 (Print Publication: 2013).
Autor:
Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska, Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Ghaemimanesh F, Daneshmanesh AH, Bayat AA, Mahmoudian J, Jeddi-Tehrani M, Rabbani H, Mellstedt H
Publikováno v:
PloS one [PLoS One] 2013 Apr 08; Vol. 8 (4), pp. e61167. Date of Electronic Publication: 2013 Apr 08 (Print Publication: 2013).
Autor:
Daneshmanesh AH; Immune and Gene Therapy Laboratory, Cancer Center Karolinska, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden., Porwit A, Hojjat-Farsangi M, Jeddi-Tehrani M, Tamm KP, Grandér D, Lehmann S, Norin S, Shokri F, Rabbani H, Mellstedt H, Österborg A
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Apr; Vol. 54 (4), pp. 843-50. Date of Electronic Publication: 2012 Oct 09.